All posts by: Michael Zand

About Michael Zand

Charity urges shorter ‘contemplation window’ to boost stem cell transplants – ITV News

Continue reading

2018-05-24 NEWS

ITV News

Charity urges shorter ‘contemplation window’ to boost stem cell transplants
ITV News
People wait for more than a year to give blood or stem cells after making an initial decision to donate, a poll suggests. The Anthony Nolan charity said there is a 15-month “contemplation window” – from the moment people first consider donation to when

Continue reading

2018-05-24 NEWS

Futurity: Research News

Embryonic stem cells form useful proto-nervous system
Futurity: Research News
It’s possible to guide human embryonic stem cells to become the precursor tissue of the central nervous system, research demonstrates. The new study also reveals the important role of mechanical signals in the development of the human nervous system.
A first look at the earliest decisions that shape a human embryoThe Rockefeller University Newswire
Elusive master organizer of human embryo growth seen for the first …Science Magazine

all 7 news articles »

Continue reading

2018-05-23 NEWS

The Ledger Gazette

3 Stocks That Feel Like Netflix in 2002
Motley Fool
It’s impossible to know which companies might have a similarly amazing run in them in the coming decades, but three Motley Fool investors see attractive parallels between Netflix in its early days and iQiyi (NASDAQ:IQ), iRobot (NASDAQ:IRBT), and Crispr …
CRISPR Therapeutics AG (CRSP) stock remained among YTD Quarterly with rise of 54.91%Street Observer (press release)
Insider Selling: CRISPR Therapeutics (CRSP) Director Sells 250000 Shares of StockThe Ledger Gazette
Chardan Capital Boosts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $72.50Macon Daily
Nasdaq Fortune (press release) –StockNewsTimes –Week Herald
all 20 news articles »